| Plasma lot |
Observed conc. (ng/mL) |
| 9-cRA |
4-oxo-9-cRA |
| LOQQC |
HQC |
LOQQC |
HQC |
| Lot- 1 |
2.68 |
361.43 |
2.30 |
151.78 |
| Lot- 1a |
2.79 |
375.32 |
2.27 |
153.37 |
| Lot- 2 |
2.56 |
390.77 |
2.42 |
144.64 |
| Lot- 2a |
2.67 |
358.56 |
2.40 |
142.91 |
| Lot- 3 |
2.86 |
352.71 |
2.25 |
145.48 |
| Lot- 3a |
2.58 |
357.69 |
2.38 |
146.30 |
| Lot- 4 |
2.79 |
371.07 |
2.30 |
152.53 |
| Lot- 4a |
2.65 |
385.25 |
2.06 |
144.35 |
| Lot- 5 |
2.63 |
356.89 |
2.36 |
139.95 |
| Lot- 5a |
2.93 |
358.12 |
2.52 |
146.95 |
| Lot- 6 |
2.71 |
356.56 |
2.11 |
141.89 |
| Lot- 6a |
2.86 |
360.02 |
2.32 |
145.13 |
| Mean |
2.73 |
365.37 |
2.31 |
146.27 |
| %CV |
4.4 |
3.4 |
5.5 |
2.9 |
| Nominal conc.(ng/mL) |
2.87 |
378.57 |
2.34 |
151.87 |
| %Nominal |
95.0 |
96.5 |
98.6 |
96.3 |
| aDuplicate; Lot 5 is haemolyzed plasma;Lot 6 islipemic plasma |
|
